These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6144670)

  • 41. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
    J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
    Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
    Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daytime carryover of triazolam and flurazepam in elderly insomniacs.
    Carskadon MA; Seidel WF; Greenblatt DJ; Dement WC
    Sleep; 1982; 5(4):361-71. PubMed ID: 6131526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    Scharf MB
    J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.
    Sateia MJ; Hauri P; Kripke D; Roehrs T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):28S-31S. PubMed ID: 2229460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The morning after: residual EEG effects of triazolam and flurazepam, alone and in combination with alcohol.
    Mendelson WB; Goodwin DW; Hill SY; Reichman JD
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):155-63. PubMed ID: 2451
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of the hypnotic activity of loprazolam, flurazepam and placebo.
    Murphy JE; Ankier SI
    Br J Clin Pract; 1984 Apr; 38(4):141-8. PubMed ID: 6144320
    [No Abstract]   [Full Text] [Related]  

  • 49. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.
    Greenblatt DJ; Harmatz JS; Engelhardt N; Shader RI
    Arch Gen Psychiatry; 1989 Apr; 46(4):326-32. PubMed ID: 2564763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative hypnotic activity of single doses of loprazolam, flurazepam, and placebo.
    Elie R; Caillé G; Levasseur FA; Gareau J
    J Clin Pharmacol; 1983 Jan; 23(1):32-6. PubMed ID: 6132929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic properties of benzodiazepine hypnotics.
    Greenblatt DJ; Abernethy DR; Divoll M; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis.
    Lindemann M; Reader A; Nusstein J; Drum M; Beck M
    J Endod; 2008 Oct; 34(10):1167-70. PubMed ID: 18793913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Controlled preoperative trials of 5 hypnotics and a placebo in 1313 patients].
    Wickström E
    Nouv Presse Med; 1979 Jul; 8(31):2561-6. PubMed ID: 386265
    [No Abstract]   [Full Text] [Related]  

  • 56. Side effects of isocarboxazid.
    Zisook S
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of triazolam, diazepam, and placebo as outpatient oral premedication for endodontic patients.
    Ehrich DG; Lundgren JP; Dionne RA; Nicoll BK; Hutter JW
    J Endod; 1997 Mar; 23(3):181-4. PubMed ID: 9594761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nighttime versus daytime hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
    Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.
    Morgan PJ; Chapados R; Chung FF; Gauthier M; Knox JW; Le Lorier J
    J Clin Anesth; 1997 Mar; 9(2):97-102. PubMed ID: 9075032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.